InvestorsHub Logo

seven-up

07/14/14 4:28 PM

#41056 RE: cashpot #41055

Thanks cashpot, good post, shows how important Biel is and going to continue being a big player in the game of pain management. The FDA approved new class is coming, maybe this week. Glad you are on TEAM BIEL
LET THE GOOD TIMES ROLL TEAM BIEL....

yankee55

07/14/14 4:58 PM

#41058 RE: cashpot #41055

Excellent post cashpot and I really think you pinpoint what is unfolding at this time with large pharms across the world:

"IcyHot Smart Relief Pain Relief TENS manufactured by the large European pharmaceutical Sanofi (33 billion annual sales). This is very good news and illustrates a positive sign of the change in the industry approach to pain control A pharma company the size of Sanofi has realized both the market need and potential market size for drug-free pain relief.."

Thanks again for sharing!

Simpsonly

07/14/14 5:07 PM

#41059 RE: cashpot #41055

Thanks for the comparison cashpot - well thought out.

In other words, there is just no comparison between TENS and BIEL's products. Apples and Oranges. Perhaps Sanofi would like a total lock on non-chemical pain management devices. Hadn't thought of that. Too obvious, I guess. I frequently thought J&J would be a logical player given the potential loss in sales of Tylenol 1 through 4 when common sense prevails about chemical drugs and their side-effects.

I also think about it this way - did the FDA have a devices division 10 years ago? It's a process and BIEL is very close. I also wonder if the FDA is perhaps working to a schedule of 60 day timing tranches? 60 days to May 21 for public comments to its Proposed Order - 60 days to July 21, or so, for it to review those comments and edit the Proposed Order to Final Oder? Just wondering.